Literature DB >> 15585919

Identification of tumor-associated autoantigens with SEREX.

Ozlem Türeci1, Dirk Usener, Sandra Schneider, Ugur Sahin.   

Abstract

Serological analysis of tumor antigens by recombinant cDNA expression cloning (SEREX) allows the systematic cloning of tumor antigens recognized by the spontaneous autoantibody repertoire of cancer patients. For SEREX, cDNA expression libraries are constructed from fresh tumor specimens, packaged into lambda-phage vectors, and expressed recombinantly in Escherichia coli. Recombinant proteins expressed during the lytic infection of bacteria are transferred onto nitrocellulose membranes to be probed with diluted autologous patient serum for identification of clones reactive with high-titered IgG antibodies. This chapter describes the SEREX technology in detail.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15585919     DOI: 10.1385/1-59259-862-5:137

Source DB:  PubMed          Journal:  Methods Mol Med        ISSN: 1543-1894


  12 in total

Review 1.  Tumor-associated antigen arrays for the serological diagnosis of cancer.

Authors:  Carlos A Casiano; Melanie Mediavilla-Varela; Eng M Tan
Journal:  Mol Cell Proteomics       Date:  2006-05-29       Impact factor: 5.911

2.  High-throughput screening for native autoantigen-autoantibody complexes using antibody microarrays.

Authors:  Jung-hyun Rho; Paul D Lampe
Journal:  J Proteome Res       Date:  2013-03-29       Impact factor: 4.466

3.  Autoantibodies to aberrantly glycosylated MUC1 in early stage breast cancer are associated with a better prognosis.

Authors:  Ola Blixt; Deanna Bueti; Brian Burford; Diane Allen; Sylvain Julien; Michael Hollingsworth; Alex Gammerman; Ian Fentiman; Joyce Taylor-Papadimitriou; Joy M Burchell
Journal:  Breast Cancer Res       Date:  2011-03-08       Impact factor: 6.466

Review 4.  Display technologies: application for the discovery of drug and gene delivery agents.

Authors:  Anna Sergeeva; Mikhail G Kolonin; Jeffrey J Molldrem; Renata Pasqualini; Wadih Arap
Journal:  Adv Drug Deliv Rev       Date:  2006-10-06       Impact factor: 15.470

5.  Cyclic Peptide Mimotopes for the Detection of Serum Anti-ATIC Autoantibody Biomarker in Hepato-Cellular Carcinoma.

Authors:  Chang-Kyu Heo; Hai-Min Hwang; Won-Hee Lim; Hye-Jung Lee; Jong-Shin Yoo; Kook-Jin Lim; Eun-Wie Cho
Journal:  Int J Mol Sci       Date:  2020-12-19       Impact factor: 5.923

6.  Biomarkers for Lung Cancer Screening and Detection.

Authors:  Edwin J Ostrin; David Sidransky; Avrum Spira; Samir M Hanash
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-10-22       Impact factor: 4.254

7.  Association of serum levels of antibodies against ALDOA and FH4 with transient ischemic attack and cerebral infarction.

Authors:  Hao Wang; Hao Lu; Xiao-Meng Zhang; Ken-Ichiro Goto; Eiichi Kobayashi; Yoichi Yoshida; Akihiko Adachi; Tomoo Matsutani; Yasuo Iwadate; Seiichiro Mine; Toshio Machida; Mizuki Sata; Kazumasa Yamagishi; Hiroyasu Iso; Norie Sawada; Shoichiro Tsugane; Ikuo Kamitsukasa; Takeshi Wada; Akiyo Aotsuka; Kazuo Sugimoto; Hirotaka Takizawa; Koichi Kashiwado; Hideo Shin; Go Tomiyoshi; Rika Nakamura; Natsuko Shinmen; Hideyuki Kuroda; Anding Xu; Takaki Hiwasa
Journal:  BMC Neurol       Date:  2021-07-09       Impact factor: 2.474

8.  Identification of a mimotope for circulating anti-cytokeratin 8/18 antibody and its usage for the diagnosis of breast cancer.

Authors:  Chang-Kyu Heo; Hai-Min Hwang; Ah Ruem; Dae-Yeul Yu; Ju Yeon Lee; Jong Shin Yoo; In Gyu Kim; Hyang Sook Yoo; Sejeong Oh; Jeong Heon Ko; Eun-Wie Cho
Journal:  Int J Oncol       Date:  2012-10-26       Impact factor: 5.650

9.  Screening of multiple myeloma by polyclonal rabbit anti-human plasmacytoma cell immunoglobulin.

Authors:  Bo Mu; Huan Zhang; Xiaoming Cai; Junbao Yang; Yuewu Shen; Baofeng Chen; Suhua Liang
Journal:  PLoS One       Date:  2013-04-01       Impact factor: 3.240

Review 10.  Autoantibodies as Potential Biomarkers in Breast Cancer.

Authors:  Jingyi Qiu; Bailey Keyser; Zuan-Tao Lin; Tianfu Wu
Journal:  Biosensors (Basel)       Date:  2018-07-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.